Excellus BlueCross BlueShield is keeping a close eye on New York state COVID-19 emergency regulations and executive orders, which continue to be extended. We are also sensitive to staffing challenges that many offices and facilities continue to experience as a result of the pandemic. Due to these considerations, we have re-evaluated the implementation of preauthorization requirements for select cardiology services through eviCore healthcare, MSI LLC, d/b/a eviCore healthcare (“eviCore healthcare”), an independent company.  

We would like to share an update on the coding required when billing for Depo-Provera (medroxyprogesterone) injections. Please submit all claims for these injections as indicated in the chart below with Healthcare Common Procedure Coding System (HCPCS) code J3490 and the appropriate National Drug Code (NDC) of the product being administered.

Excellus BlueCross BlueShield works to ensure that the development of corporate medical policies occurs through an open, collaborative process. We encourage participating providers to become actively involved in medical policy development.